CA2107463A1 - Totipotent hematopoietic stem cell receptors and their ligands - Google Patents
Totipotent hematopoietic stem cell receptors and their ligandsInfo
- Publication number
- CA2107463A1 CA2107463A1 CA002107463A CA2107463A CA2107463A1 CA 2107463 A1 CA2107463 A1 CA 2107463A1 CA 002107463 A CA002107463 A CA 002107463A CA 2107463 A CA2107463 A CA 2107463A CA 2107463 A1 CA2107463 A1 CA 2107463A1
- Authority
- CA
- Canada
- Prior art keywords
- ligands
- flk
- nucleic acid
- expressed
- receptor protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Isolated mammalian nucleic acid molecules encoding receptor protein tyrosine kinases expressed in primitive hematopoie-tic cells and not expressed in mature hematopoietic cells are provided. Also included are the receptors encoded by such nucleic acid molecules; the nucleic acid molecules encoding receptor protein tyrosine kinases having the sequences shown in Figure 1 (flk-2) and Figure 2(flk-1); the receptor protein tyrosine kinases having the amino acid sequences shown in Figure 1 (flk-2) and Figure 2 (flk-1); ligands for the receptors; nucleic acid sequences that encode the ligands; and methods of stimulating the prolif-eration and/or differentiation of primitive mammalian hematopoietic stem cells comprising contacting the stem cells with a li-gand that binds to a receptor protein tyrosine kinase expressed in primitive mammalian hematopoietic cells and not expressed in mature hematopoietic cells.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67966691A | 1991-04-02 | 1991-04-02 | |
US07/679,666 | 1991-04-02 | ||
US72891391A | 1991-06-28 | 1991-06-28 | |
US07/728,913 | 1991-06-28 | ||
US79306591A | 1991-11-15 | 1991-11-15 | |
US07/793,065 | 1991-11-15 | ||
US07/813,593 US5185438A (en) | 1991-04-02 | 1991-12-24 | Nucleic acids encoding hencatoporetic stem cell receptor flk-2 |
US07/813,593 | 1991-12-24 | ||
PCT/US1992/002750 WO1992017486A1 (en) | 1991-04-02 | 1992-04-02 | Totipotent hematopoietic stem cell receptors and their ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2107463A1 true CA2107463A1 (en) | 1992-10-03 |
CA2107463C CA2107463C (en) | 2008-06-17 |
Family
ID=27505386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002107463A Expired - Lifetime CA2107463C (en) | 1991-04-02 | 1992-04-02 | Totipotent hematopoietic stem cell receptors and their ligands |
Country Status (7)
Country | Link |
---|---|
US (3) | US5185438A (en) |
EP (6) | EP1231261B1 (en) |
KR (3) | KR100261465B1 (en) |
AU (1) | AU1924892A (en) |
CA (1) | CA2107463C (en) |
DE (5) | DE69232952T2 (en) |
WO (2) | WO1992017486A1 (en) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030206899A1 (en) * | 1991-03-29 | 2003-11-06 | Genentech, Inc. | Vascular endothelial cell growth factor antagonists |
US6582959B2 (en) * | 1991-03-29 | 2003-06-24 | Genentech, Inc. | Antibodies to vascular endothelial cell growth factor |
US5367057A (en) | 1991-04-02 | 1994-11-22 | The Trustees Of Princeton University | Tyrosine kinase receptor flk-2 and fragments thereof |
US5270458A (en) * | 1991-04-02 | 1993-12-14 | The Trustees Of Princeton University | Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2 |
US5185438A (en) * | 1991-04-02 | 1993-02-09 | The Trustees Of Princeton University | Nucleic acids encoding hencatoporetic stem cell receptor flk-2 |
US6331302B1 (en) * | 1992-01-22 | 2001-12-18 | Genentech, Inc. | Protein tyrosine kinase agonist antibodies |
US5861301A (en) * | 1992-02-20 | 1999-01-19 | American Cayanamid Company | Recombinant kinase insert domain containing receptor and gene encoding same |
US6228609B1 (en) * | 1992-07-09 | 2001-05-08 | Systemix, Inc. | Soluble Flk-2 sequence |
US6824777B1 (en) | 1992-10-09 | 2004-11-30 | Licentia Ltd. | Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
US6107046A (en) * | 1992-10-09 | 2000-08-22 | Orion Corporation | Antibodies to Flt4, a receptor tyrosine kinase and uses thereof |
US5776755A (en) * | 1992-10-09 | 1998-07-07 | Helsinki University Licensing, Ltd. | FLT4, a receptor tyrosine kinase |
US5981569A (en) * | 1992-11-13 | 1999-11-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease |
US5763441A (en) * | 1992-11-13 | 1998-06-09 | Sugen, Inc. | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
US5792771A (en) * | 1992-11-13 | 1998-08-11 | Sugen, Inc. | Quinazoline compounds and compositions thereof for the treatment of disease |
US6872699B2 (en) | 1992-11-13 | 2005-03-29 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften, E.V. | Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein |
US6177401B1 (en) | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
US5712395A (en) * | 1992-11-13 | 1998-01-27 | Yissum Research Development Corp. | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
CN1173991C (en) * | 1992-11-13 | 2004-11-03 | 马克斯普朗克科学促进协会 | Fik-1 as receiptor of growth factor of blood vessel inner-skin |
WO1994019463A2 (en) * | 1993-02-16 | 1994-09-01 | Auckland Uniservices Limited | Developmental tyrosine kinases and their ligands |
JPH09501822A (en) * | 1993-05-19 | 1997-02-25 | シェリング・コーポレーション | Purified mammalian FLT3 ligand and agonists and antagonists thereof |
US7534867B1 (en) | 1993-05-19 | 2009-05-19 | Schering Corporation | Purified mammalian Flt3 ligands; agonists; antagonists |
US5554512A (en) * | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
US7045128B2 (en) | 1993-05-24 | 2006-05-16 | Immunex Corporation | Antibodies against flt3-ligand |
NZ314644A (en) | 1993-05-24 | 2000-11-24 | Immunex Corp | Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue |
US6630143B1 (en) * | 1993-05-24 | 2003-10-07 | Immunex Corporation | Antibodies against flt3 ligand |
AU7210394A (en) * | 1993-06-18 | 1995-01-17 | Trustees Of Princeton University, The | Totipotent hematopoietic stem cell receptors and their ligands |
US5516658A (en) | 1993-08-20 | 1996-05-14 | Immunex Corporation | DNA encoding cytokines that bind the cell surface receptor hek |
JPH09502352A (en) * | 1993-09-08 | 1997-03-11 | イムクローン システムズ インコーポレイテッド | Isolation of a monoclonal antibody recognizing the FLK-2 receptor and a primitive hematopoietic stem cell population |
US6001621A (en) * | 1993-11-23 | 1999-12-14 | Genetech, Inc. | Protein tyrosine kinases |
EP0730646A1 (en) * | 1993-11-23 | 1996-09-11 | Genentech, Inc. | PROTEIN TYROSINE KINASES NAMED Rse |
US6190655B1 (en) | 1993-12-03 | 2001-02-20 | Immunex Corporation | Methods of using Flt-3 ligand for exogenous gene transfer |
US5618709A (en) * | 1994-01-14 | 1997-04-08 | University Of Pennsylvania | Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein |
US5573935A (en) * | 1994-01-18 | 1996-11-12 | The United States Of America As Represented By The Department Of Health And Human Services | Protein tyrosine kinase A6 |
US5840301A (en) * | 1994-02-10 | 1998-11-24 | Imclone Systems Incorporated | Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors |
US5861499A (en) | 1994-02-10 | 1999-01-19 | Imclone Systems Incorporated | Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain |
US6811779B2 (en) * | 1994-02-10 | 2004-11-02 | Imclone Systems Incorporated | Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy |
US6448077B1 (en) * | 1994-02-10 | 2002-09-10 | Imclone Systems, Inc. | Chimeric and humanized monoclonal antibodies specific to VEGF receptors |
US20030108545A1 (en) * | 1994-02-10 | 2003-06-12 | Patricia Rockwell | Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
US7294331B2 (en) * | 1994-03-07 | 2007-11-13 | Immunex Corporation | Methods of using flt3-ligand in hematopoietic cell transplantation |
US7186688B1 (en) | 1994-03-08 | 2007-03-06 | Human Genome Sciences, Inc. | Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 |
US7153827B1 (en) | 1994-03-08 | 2006-12-26 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 and methods of use |
WO1995024473A1 (en) * | 1994-03-08 | 1995-09-14 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
US6608182B1 (en) | 1994-03-08 | 2003-08-19 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 2 |
US6040157A (en) * | 1994-03-08 | 2000-03-21 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
US7109308B1 (en) * | 1994-03-08 | 2006-09-19 | Human Genome Sciences, Inc. | Antibodies to human vascular endothelial growth factor 2 |
US5932540A (en) | 1994-03-08 | 1999-08-03 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
US6734285B2 (en) | 1994-03-08 | 2004-05-11 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 proteins and compositions |
US6140119A (en) * | 1994-09-16 | 2000-10-31 | Michigan State University | Expression of estrogen receptors in type I and type II human breast epithelial cells |
US5650317A (en) * | 1994-09-16 | 1997-07-22 | Michigan State University | Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics |
US5731425A (en) * | 1994-10-28 | 1998-03-24 | Eastman Kodak Company | Polypeptide surface marker for cells |
NZ300808A (en) * | 1994-12-23 | 1999-04-29 | Ludwig Inst Cancer Res | A method of detecting a ligand capable of binding the receptor protein nyk |
US7070972B1 (en) * | 1995-01-13 | 2006-07-04 | The United States Of America As Represented By The Department Of Health And Human Services | Janus family kinases and identification of immune modulators |
IL117645A (en) * | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
US5824789A (en) * | 1995-06-07 | 1998-10-20 | Systemix, Inc. | Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof |
EP1382679A3 (en) * | 1995-09-08 | 2004-11-10 | Genentech, Inc. | Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
US20020034517A1 (en) * | 1995-10-04 | 2002-03-21 | Kenneth Brasel | Dendritic cell stimulatory factor |
US7361330B2 (en) * | 1995-10-04 | 2008-04-22 | Immunex Corporation | Methods of using flt3-ligand in the treatment of fibrosarcoma |
US7150992B1 (en) | 1995-10-04 | 2006-12-19 | Innunex Corporation | Methods of preparing dendritic cells with flt3-ligand and antigen |
WO1997017442A1 (en) * | 1995-11-08 | 1997-05-15 | Immunex Corporation | Flk-1 binding protein |
US6994989B1 (en) | 1995-11-08 | 2006-02-07 | Immunex Corp. | FLK-1 binding proteins |
US5869243A (en) * | 1996-03-05 | 1999-02-09 | Rhode Island Hospital | Immortalized hepatocytes |
US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
US6750044B1 (en) | 1996-10-17 | 2004-06-15 | Genentech, Inc. | Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids |
US20060171907A1 (en) * | 1996-11-21 | 2006-08-03 | The Procter & Gamble Company | Oral care compositions providing enhanced whitening and stain prevention |
JP2002500879A (en) * | 1998-01-23 | 2002-01-15 | イムクローン システムズ インコーポレーテッド | Population of stem cells |
US6908898B1 (en) * | 1998-06-15 | 2005-06-21 | Lars Holmgren | Angiogenesis related molecules |
CN100340291C (en) * | 1998-10-09 | 2007-10-03 | 路德维格癌症研究院 | F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy |
US8124630B2 (en) * | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
WO2000041698A1 (en) * | 1999-01-13 | 2000-07-20 | Bayer Corporation | φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
US20020064528A1 (en) * | 2000-01-28 | 2002-05-30 | Zhenping Zhu | Antibodies specific to KDR and uses thereof |
US7223724B1 (en) | 1999-02-08 | 2007-05-29 | Human Genome Sciences, Inc. | Use of vascular endothelial growth factor to treat photoreceptor cells |
US6379903B1 (en) | 1999-10-08 | 2002-04-30 | Sigma-Aldrich Co. | Purification of recombinant proteins fused to multiple epitopes |
AU6821301A (en) | 2000-06-07 | 2001-12-17 | Ortho Mcneil Pharm Inc | Method to detect modulators of vegf kinase domain |
US7273751B2 (en) * | 2000-08-04 | 2007-09-25 | Human Genome Science, Inc. | Vascular endothelial growth factor-2 |
JP4669984B2 (en) | 2001-01-19 | 2011-04-13 | ベジェニクス リミテッド | F1t4 (VEGFR-3) and antitumor therapy as a target for tumor imaging |
US7402312B2 (en) * | 2001-04-13 | 2008-07-22 | Human Genome Sciences, Inc. | Antibodies to vascular endothelial growth factor 2 (VEGF-2) |
US20030170786A1 (en) * | 2001-04-13 | 2003-09-11 | Rosen Craig A. | Vascular endothelial growth factor 2 |
US20050232921A1 (en) * | 2001-04-13 | 2005-10-20 | Rosen Craig A | Vascular endothelial growth factor 2 |
ATE470676T1 (en) * | 2001-04-13 | 2010-06-15 | Human Genome Sciences Inc | ANTI-VEGF-2 ANTIBODIES |
AU2002252631A1 (en) * | 2001-04-13 | 2002-10-28 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
US7371763B2 (en) * | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
AU2002316305A1 (en) * | 2001-06-20 | 2003-01-08 | Vlaams Interuniversitair Institut Voor Biotechnologie | Method of treating atherosclerosis and other inflammatory diseases |
EP1423012B1 (en) * | 2001-08-10 | 2007-11-14 | Imclone Systems, Inc. | Medical use of stem cells expressing vegfr-1 |
US20080108672A1 (en) * | 2002-01-11 | 2008-05-08 | Bernd Riedl | Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors |
PT1478358E (en) * | 2002-02-11 | 2013-09-11 | Bayer Healthcare Llc | Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis |
US7557129B2 (en) * | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
PL1626714T3 (en) * | 2003-05-20 | 2007-12-31 | Bayer Healthcare Llc | Diaryl ureas for diseases mediated by pdgfr |
CN1856469B (en) | 2003-07-23 | 2013-03-06 | 拜耳医药保健有限责任公司 | Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
EP2377555A3 (en) | 2004-11-18 | 2011-11-23 | Imclone LLC | Antibodies against vascular endothelial growth factor receptor-1 |
US7495383B2 (en) * | 2005-08-01 | 2009-02-24 | Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. | Phosphor based on a combination of quantum dot and conventional phosphors |
KR100883430B1 (en) * | 2007-06-13 | 2009-02-12 | 한국생명공학연구원 | Human Monoclonal Antibody Neutralizing Vesicular Endothelial Growth Factor Receptor and Use Thereof |
AR071891A1 (en) | 2008-05-30 | 2010-07-21 | Imclone Llc | ANTI-FLT3 HUMAN ANTIBODIES (THIROSINE KINASE 3 RECEPTOR HUMAN FMS TYPE) |
WO2010071692A2 (en) * | 2008-06-18 | 2010-06-24 | Innovative Biotherapies, Inc. | Methods for enhanced propagation of cells |
US9745558B2 (en) | 2013-02-18 | 2017-08-29 | Vegenics Pty Limited | VEGFR-3 ligand binding molecules and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2035317T5 (en) * | 1987-11-09 | 1998-03-16 | Becton Dickinson Co | METHOD FOR ANALYZING HEMATOPOYETIC CELLS IN A SAMPLE. |
HUT53672A (en) * | 1988-02-25 | 1990-11-28 | Gen Hospital Corp | Quick immunoselective cloning process |
US5081030A (en) * | 1989-04-25 | 1992-01-14 | The Johns Hopkins University | Release of cells from affinity matrices |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5185438A (en) * | 1991-04-02 | 1993-02-09 | The Trustees Of Princeton University | Nucleic acids encoding hencatoporetic stem cell receptor flk-2 |
-
1991
- 1991-12-24 US US07/813,593 patent/US5185438A/en not_active Expired - Lifetime
-
1992
- 1992-04-02 EP EP02004001A patent/EP1231261B1/en not_active Expired - Lifetime
- 1992-04-02 EP EP92911275A patent/EP0580760B1/en not_active Expired - Lifetime
- 1992-04-02 DE DE69232952T patent/DE69232952T2/en not_active Expired - Lifetime
- 1992-04-02 EP EP07001970A patent/EP1808445A3/en not_active Withdrawn
- 1992-04-02 WO PCT/US1992/002750 patent/WO1992017486A1/en active IP Right Grant
- 1992-04-02 EP EP02004000A patent/EP1231260B1/en not_active Expired - Lifetime
- 1992-04-02 KR KR1019930702936A patent/KR100261465B1/en not_active IP Right Cessation
- 1992-04-02 DE DE69233788T patent/DE69233788D1/en not_active Expired - Lifetime
- 1992-04-02 CA CA002107463A patent/CA2107463C/en not_active Expired - Lifetime
- 1992-04-02 DE DE69233676T patent/DE69233676T2/en not_active Expired - Lifetime
- 1992-04-02 DE DE69232687T patent/DE69232687T2/en not_active Expired - Lifetime
- 1992-04-02 AU AU19248/92A patent/AU1924892A/en not_active Abandoned
- 1992-04-02 EP EP02004002A patent/EP1231265B1/en not_active Expired - Lifetime
- 1992-04-02 DE DE69233746T patent/DE69233746D1/en not_active Expired - Lifetime
- 1992-04-02 EP EP98119396A patent/EP0909813B1/en not_active Expired - Lifetime
- 1992-04-02 KR KR10-2000-7000871A patent/KR100407010B1/en not_active IP Right Cessation
- 1992-06-26 WO PCT/US1992/005401 patent/WO1993000349A1/en active Application Filing
- 1992-06-26 US US07/906,397 patent/US5621090A/en not_active Expired - Lifetime
- 1992-09-17 US US07/946,507 patent/US5283354A/en not_active Expired - Lifetime
-
1999
- 1999-09-15 KR KR1019990039635A patent/KR100406832B1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2107463A1 (en) | Totipotent hematopoietic stem cell receptors and their ligands | |
CA2174746A1 (en) | Embryonic stem cells capable of differentiating into desired cell lines | |
EP0307247A3 (en) | A method for culturing recombinant cells | |
EP0669929A4 (en) | Novel cytokine designated elk ligand. | |
WO1988002406A3 (en) | Methods of regulating metabolic stability of proteins | |
HUP0000317A3 (en) | Process for the preparation of recombinant proteins in e.coli by high cell density fermentation | |
EP0536350A4 (en) | Identification of a novel human receptor tyrosine kinase gene. | |
EP0653940A4 (en) | Glial mitogenic factors, their preparation and use. | |
IL173399A0 (en) | Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy | |
AU6569386A (en) | Eukaryotic fusion proteins, the preparation and use thereof and means for carrying out the process | |
CA2195799A1 (en) | Bacterial production of hydrophobic polypeptides | |
WO1995000554A3 (en) | Totipotent hematopoietic stem cell receptors and their ligands | |
IL135911A0 (en) | Dna 19355 polypeptide, a tumor necrosis factor homolog | |
WO1999006557A3 (en) | Mammalian cell membrane proteins; related reagents | |
CA2328423A1 (en) | Amino acid modified polypeptides | |
Echandi et al. | Protein synthesis and ribosomal distribution in a polyamine auxotroph of Escherichiacoli: Studies in cell-free systems | |
WO2002008417A1 (en) | Process for producing recombinant protein | |
CA2241367A1 (en) | Vector for expression of n-terminally extended proteins in yeast cell | |
SI0658626T1 (en) | Methods for producing protein C | |
WO1997022690A3 (en) | SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES (SIPs) | |
IL127363A0 (en) | IL-1/TNF-alpha-activated kinase and methods of making and using the same | |
WO1994019463A3 (en) | Developmental tyrosine kinases and their ligands | |
IL131103A0 (en) | The neurotrophic factor nnt-1 | |
CA2246430A1 (en) | Protein tyrosine phosphatases of hematopoietic cells | |
EP1434483A4 (en) | Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |